T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Sales | 120 | 0 | 0 |
| Gross Profit | 120 | N/A | N/A |
| Operating Expenses | 5,030 | 4,600 | 0 |
| Operating Income | -4,910 | -4,600 | N/A |
| Interest Expense | 104 | 105 | 0 |
| Other Income | 0 | 125 | 0 |
| Pre-tax Income | -5,014 | -4,580 | 0 |
| Net Income Continuous | -5,014 | -4,580 | N/A |
| Net Income | $-5,014 | $-4,580 | $N/A |
| EPS Basic Total Ops | -24,750.00 | -20,850.00 | N/A |
| EPS Basic Continuous Ops | -17,932.76 | -16,594.21 | N/A |
| EPS Diluted Total Ops | -24,750.00 | -20,850.00 | N/A |
| EPS Diluted Continuous Ops | -17,932.76 | -16,594.21 | N/A |
| EBITDA(a) | $-4,764 | $-4,462 | $N/A |